Abstract:AbstractAimsThe co‐morbidities contribute to the inferior prognosis of COVID‐19 patients. Recent reports suggested that the higher co‐morbidity rate between COVID‐19 and heart failure (HF) leads to increased mortality. However, the common pathogenic mechanism between them remained elusive. Here, we aimed to reveal underlying molecule mechanisms and genetic correlation between COVID‐19 and HF, providing a new perspective on current clinical management for patients with co‐morbidity.MethodsThe gene expression profiles of HF (GSE26887) and COVID‐19 (GSE147507) were retrieved from the GEO database. After identifying the common differentially expressed genes (|log2FC| > 1 and adjusted P < 0.05), integrated analyses were performed, namely, enrichment analyses, protein–protein interaction network, module construction, critical gene identification, and functional co‐expression analysis. The performance of critical genes was validation combining hierarchical clustering, correlation, and principal component analysis in external datasets (GSE164805 and GSE9128). Potential transcription factors and miRNAs were obtained from the JASPER and RegNetwork repository used to construct co‐regulatory networks. The candidate drug compounds in potential genetic link targets were further identified using the DSigDB database.ResultsThe alteration of 12 genes was identified as a shared transcriptional signature, with the role of immune inflammatory pathway, especially Toll‐like receptor, NF‐kappa B, chemokine, and interleukin‐related pathways that primarily emphasized in response to SARS‐CoV‐2 complicated with HF. Top 10 critical genes (TLR4, TLR2, CXCL8, IL10, STAT3, IL1B, TLR1, TP53, CCL20, and CXCL10) were identified from protein–protein interaction with topological algorithms. The unhealthy microbiota status and gut–heart axis in co‐morbidity were identified as potential disease roads in bridging pathogenic mechanism, and lipopolysaccharide acts as a potential marker for monitoring HF during COVID‐19. For transcriptional and post‐transcriptional levels, regulation networks tightly coupling with both disorders were constructed, and significant regulator signatures with high interaction degree, especially FOXC1, STAT3, NF‐κB1, miR‐181, and miR‐520, were detected to regulate common differentially expressed genes. According to genetic links targets, glutathione‐based antioxidant strategy combined with muramyl dipeptide‐based microbe‐derived immunostimulatory therapies was identified as promising anti‐COVID‐19 and anti‐HF therapeutics.ConclusionsThis study identified shared transcriptomic and corresponding regulatory signatures as emerging therapeutic targets and detected a set of pharmacologic agents targeting genetic links. Our findings provided new insights for underlying pathogenic mechanisms between COVID‐19 and HF.

STAT4 and COL1A2 are potential diagnostic biomarkers and therapeutic targets for heart failure comorbided with depression

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

Analysis of Communal Molecular Mechanism and Potential Therapeutic Targets in Heart Failure and Type 2 Diabetes Mellitus

Mining Potential Drug Targets and Constructing Diagnostic Models for Heart Failure Based on Mirna-Mrna Networks

The Bioinformatical Identification of Potential Biomarkers in Heart Failure Diagnosis and Treatment

Screening of Secretory Proteins Linking Major Depressive Disorder with Heart Failure Based on Comprehensive Bioinformatics Analysis and Machine Learning

Identification of shared molecular mechanisms and diagnostic biomarkers between heart failure and idiopathic pulmonary fibrosis

Identification of Key Genes and Regulatory Networks Involved in the Comorbidity of Atrial Fibrillation and Chronic Obstructive Pulmonary Disease

Potential shared gene signatures and molecular mechanisms between atherosclerosis and depression: Evidence from transcriptome data

Investigation of the shared molecular mechanisms and hub genes between myocardial infarction and depression

Exploring the bi-directional relationship and shared genes between depression and stroke via NHANES and bioinformatic analysis

Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis

Identification of Independent and Communal Differentially Expressed Genes As Well As Potential Therapeutic Targets in Ischemic Heart Failure and Non-Ischemic Heart Failure.

The Identification of Key Genes and Biological Pathways in Heart Failure by Integrated Bioinformatics Analysis

Systematic analysis of molecular mechanisms of heart failure through the pathway and network-based approach

Identification of potential biomarkers and candidate small- molecule drugs for heart failure via comprehensive gene microarray analysis

A Bibliometric Analysis of Research on Heart Failure Comorbid with Depression from 2002 to 2021

Weighted Correlation Network Bioinformatics Uncovers a Key Molecular Biosignature Driving the Left-Sided Heart Failure.

Identification of Hub Diagnostic Biomarkers and Candidate Therapeutic Drugs in Heart Failure

Uncovering the Genetic Links of SARS‐CoV‐2 Infections on Heart Failure Co‐morbidity by a Systems Biology Approach

Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure